The guy does multiple multi hour webinars with unfiltered questions which is pretty much unheard of.pretty heard to speak off the cuff like that while also trying to predict how the market will or won't interpret every little thing he says.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
